Length of whole blood clots from different amounts of blood in the in vitro middle cerebral artery model (diameter 3.1 mm). by Jan Víteček (11434774)

Experimental study groups and the number of animals within each. by Harry A. Quigley (695817)

Primary antibodies used for histological studies and Immunoblot. by Harry A. Quigley (695817)

STPKLRR is an effector secreted by AJ01 T3SS. by Fa Dai (15810913)

Multivariable model for percent axon loss. by Harry A. Quigley (695817)

Axon loss by treatment group. by Harry A. Quigley (695817)

Tonolab Calibration. by Harry A. Quigley (695817)

Results of the fitting process of the basic epidemiological model (i.e., without vaccinations). by Matthias Horn (78815)

Pressure—strain estimates in load—unload protocol for losartan and control groups. by Harry A. Quigley (695817)

Photoreceptor cell death and protective effect of the blue-blocking filter on cone photoreceptors. by Javier Vicente-Tejedor (4966858)

The effect of losartan on creep rate in ramp—hold inflation studies. by Harry A. Quigley (695817)

Movement variability conditioned on task outcome. by Adam M. Roth (19845864)

Image_1_GlnR-Mediated Regulation of Short-Chain Fatty Acid Assimilation in Mycobacterium smegmatis.TIF by Xin-Xin Liu (5437628)

CD4 cell count at viral set-point and mean CD4 cell count at each time period. by Luuk Gras (370061)

Adult social behavior to a conspecific. by Gordon A. Barr (11163243)

Sensitivity of mean population biomass and cumulative harvest to initial biomass to the rate of demographic change due to climate impacts. by Jameal F. Samhouri (10136090)

“…All parameters are at their default values (<a href="/article/info:doi/10.1371/journal.pclm.0000624#pclm.0000624.s002" target="_blank">S1 Table</a>); note that initial and final values of <i>r</i> and <i>K</i> differ in the decreasing versus increasing scenarios (<a href="/article/info:doi/10.1371/journal.pclm.0000624#pclm.0000624.s003" target="_blank">S2 Table</a>). …”

Western blots comparing losartan and water groups. by Harry A. Quigley (695817)

Experimental design. by Xueyan Lin (448667)

“…The C and MNS group were gavaged with equal volume normal saline, the ML and MR group gavaged with lactulose at a dose of 10 mL/kg body weight and rifaximin at a dose of 50 mg/kg body weight respectively once a day for 8 weeks until the end of the experiment. …”

Histological evaluation of joints after oral administration of GLME to rats with MIA-induced OA. by JooYeon Jhun (3797404)

Parkinson’s and age-matched control results. by Adam M. Roth (19845864)